About Curiosis
Curiosis is a publicly listed company based in South Korea founded in 2015. It provides cell imaging systems and lab automation for scientific research. It operates on a B2B and D2C model. Curiosis offers products and services including Celloger® Pro, Celloger® Stack, MSP™ 320, FACSCOPE® B, and Cellpuri®. Its focus areas include Biotech, Cell Imaging, Live Cell Monitoring and Medical Devices. Its legal entity is Curiosis Inc.
Company details
Curiosis develops advanced technologies for cell imaging, cell counting, isolation, and digital pathology. They offer products like the Celloger series for real-time monitoring in incubators and MSP for high-resolution slide scanning. Based in Seoul, Republic of Korea, the company focuses on enhancing lab productivity through innovative solutions, serving researchers in biotechnology and healthcare sectors.
- Headquarters South Korea
- Stage Public
- SectorsHealthcare
- Website curiosis.com
- Social LinkedIn Facebook YouTube
- Legal Name Curiosis Inc
Products & Services of Curiosis
Curiosis offers a comprehensive portfolio of products and services, including Celloger® Pro, Celloger® Stack, MSP™ 320, FACSCOPE® B, and Cellpuri®.
System for real-time cell monitoring inside incubators
Platform for multi-layer cell observation and culture
High-resolution scanner for digital slide analysis
Tool for automated cell counting and analysis
System for automated cell separation processes
Apps and channels of Curiosis
its YouTube channel Curiosis Inc. has 388 subscribers and 30 videos.
Videos from Curiosis
The most watched videos on Curiosis's YouTube channel, Curiosis Inc. (388 subscribers). Click a video to play it here.
More on Curiosis Inc..
IPO & Listings of Curiosis
Curiosis is a publicly listed company on the KRX with ticker symbol 494120 in South Korea. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date13 Nov 2025
- Listed onKRX: 494120
- Listed entityCURIOSIS INC
- ISINKR7494120009
- Share price7,600.00 KRW (-4.28% on the day) · 2026-10-14
- Market capitalisation121,162,523,918.00 KRW
- EPS (diluted, trailing year)-517.83 KRW
- Volume (last session)91,181
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Curiosis
Complete news archive for Curiosis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curiosis
Curiosis was founded in 2015.
Curiosis is headquartered in South Korea.
Curiosis develops advanced technologies for cell imaging, cell counting, isolation, and digital pathology. They offer products like the Celloger series for real-time monitoring in incubators and MSP for high-resolution slide scanning. Based in Seoul, Republic of Korea, the company focuses on enhancing lab productivity through innovative solutions, serving researchers in biotechnology and healthcare sectors.
Curiosis offers Celloger® Pro, Celloger® Stack, MSP™ 320, FACSCOPE® B, and Cellpuri®.
Yes, Curiosis is publicly traded on KRX under the ticker symbol 494120.
Curiosis operates through Curiosis Inc..